Home / BlackRock and iShares / BlackRock Health Sciences Trust
BlackRock Health Sciences Trust
fund voting report, part of BlackRock and iShares
- Vote records reported
- 1,190year to 30 June 2026
- Against management
- 3.5%41 of 1,185 marked votes
- Say-on-pay support
- 92.4%for, of for + against + abstain
- Shareholder-proposal support
- 0.0%for, of for + against + abstain
foragainstabstain, withhold or otheramber tick: the portion cast against management
BlackRock Health Sciences Trust reported 1,190 vote records for the year to 30 June 2026. It marked 3.5% of its votes as cast against management (41 of 1,185), 2.8 percentage points below the median fund registrant, which was 6.2%.
Weighted by the number of shares voted, the against-management share is 1.9%. The two figures differ when the votes against management fall on larger or smaller holdings than the rest.
On pay and on shareholder proposals: it voted for 92.4% of the section 14A say-on-pay items it reported (the median fund registrant: 91.6%) and it voted for 0.0% of the proposals put forward by security holders (the median fund registrant: 27.5%).
By category, votes against management were most frequent in COMPENSATION (6.9% of 58), SECTION 14A SAY-ON-PAY VOTES (6.9% of 131) and CORPORATE GOVERNANCE (4.8% of 63).
It reported 482,940 shares out on loan at record dates, 1.02% of the shares it held or had lent across the meetings it reported. Shares on loan are not voted.
Compared with other filers
Each rate is defined once, in the methodology. The median is taken over 1,241 fund registrants with at least 25 vote records in the season.
| year to 30 June 2026 | This filer | Median fund registrant | All filers pooled |
|---|---|---|---|
| Against-management share | 3.5% | 6.2% | 10.6% |
| Say-on-pay support rate | 92.4% | 91.6% | 86.0% |
| Shareholder-proposal support rate | 0.0% | 27.5% | 33.9% |
| Shares on loan, share of shares held | 1.02% | 0.00% | 3.12% |
| Largest families, year to 30 June 2026 | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|
| Vanguard | 20.1% | 94.1% | 42.0% |
| BlackRock and iShares | 7.5% | 88.3% | 11.9% |
| Fidelity | 6.0% | 94.7% | 27.6% |
| Dimensional | 16.4% | 78.9% | 57.4% |
| State Street and SPDR | 16.9% | 77.1% | 50.4% |
Votes by category
Filers choose one or more categories for each vote, so a vote can appear in more than one row. Category names are printed as Form N-PX defines them.
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 744 | 718 | 5 | 3.2% | |
| SECTION 14A SAY-ON-PAY VOTES | 131 | 110 | 9 | 6.9% | |
| AUDIT-RELATED | 128 | 128 | 0 | 0.0% | |
| SHAREHOLDER RIGHTS AND DEFENSES | 19 | 14 | 5 | 0.0% | |
| EXTRAORDINARY TRANSACTIONS | 10 | 10 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 33 | 32 | 1 | 3.0% | |
| COMPENSATION | 58 | 53 | 5 | 6.9% | |
| CORPORATE GOVERNANCE | 66 | 47 | 16 | 4.8% | |
| HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE | 3 | 0 | 3 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 1 | 0 | 1 | 0.0% | |
| OTHER SOCIAL ISSUES | 9 | 5 | 4 | 0.0% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support | Split |
|---|---|---|---|---|---|
| year to 30 June 2024 | 1,264 | 5.8% | 93.3% | 8.2% | |
| year to 30 June 2025 | 1,107 | 4.5% | 93.9% | 3.2% | |
| year to 30 June 2026 | 1,190 | 3.5% | 92.4% | 0.0% |
Say-on-pay votes against management
Counting one say-on-pay item per company meeting, BlackRock Health Sciences Trust voted against management on 9 of the 114 it marked either way (7.9%) in the year to 30 June 2026.
- Thermo Fisher Scientific Inc. 20 May 2026
- Moderna, Inc. 6 May 2026
- The Cooper Companies, Inc. 7 Apr 2026
- Bio-Techne Corporation 30 Oct 2025
- Scholar Rock Holding Corporation 4 Jun 2026
- Ocular Therapeutix, Inc. 10 Jun 2026
- Summit Therapeutics Inc. 10 Jun 2026
- BIONTECH SE 15 May 2026
- Galderma Group AG 22 Apr 2026
Shareholder proposals it supported
Of 24 proposals from security holders that could be told apart in the filings and on which it cast a vote, BlackRock Health Sciences Trust voted for 0 (0.0%). Titles are the most common wording among filers; where a wording could name a person, the SEC category is printed instead.
Shares on loan
BlackRock Health Sciences Trust reported 482,940 shares on loan at record dates against 46.9 million shares voted: 1.02% of the two together. Median fund registrant: 0.00%. Shares lent out at the record date cannot be voted by the lender, which is why Form N-PX asks for the figure. More on lending and votes.
The filings
These figures are read from the filer's own Form N-PX. If a vote on this page looks wrong, the filing is the record: a dispute about a filed vote is a matter for the filer, and an error in how this site read the filing is a matter for corrections.
- N-PX filed 28 Aug 2026 accession 0001438934-26-002387
- Every N-PX filing by this filer on EDGAR
Questions
How did BlackRock Health Sciences Trust vote on executive pay?
In the year to 30 June 2026 BlackRock Health Sciences Trust reported 119 votes in the category SECTION 14A SAY-ON-PAY VOTES that were cast for, against or abstain. 110 were for (92.4%), 9 against and 0 abstentions. Counting one item per company meeting, it voted against management on 9 of the 114 say-on-pay items it marked either way.
How often does BlackRock Health Sciences Trust vote against management?
3.5% of the time in the year to 30 June 2026: 41 of the 1,185 votes it marked as for or against management. Form N-PX asks each filer to state, vote by vote, whether the vote was for or against management's recommendation; this figure counts those marks.
Did BlackRock Health Sciences Trust support shareholder proposals on climate?
It reported no votes on security-holder proposals in the category ENVIRONMENT OR CLIMATE for the year to 30 June 2026. Across every category it voted for 0.0% of security-holder proposals.
Is this the result of the meetings?
No. Form N-PX shows how this filer voted the shares it held. It does not show how other shareholders voted or whether a proposal was approved. Companies report certified results separately, on Form 8-K.
Where does the data come from?
From the Form N-PX filings of this filer on the SEC's EDGAR system, read as filed. The SEC does not verify the contents. Amended filings (N-PX/A) replace the filings they amend. Data on this page runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings by BlackRock Health Sciences Trust (filer no. 1314966), read as filed and not verified by the SEC. Amended filings replace the filings they amend. Filings read through 23 Sep 2026; page built 26 Sep 2026.